16th Dec 2015 08:27
LONDON (Alliance News) - Transdermal technology healthcare company Futura Medical PLC on Wednesday said it has achieved a significantly extended shelf-life for its CSD500 condom, compared to the currently approved shelf life of one year.
Futura said the improved shelf life has been achieved by using a modified manufacturing process and a regulatory submission for the product will be made soon.
The company said it is working with its commercial partners on timetables for the launch of the product and expects it to be licensed for sale in 31 countries in total.
"We are now sufficiently confident to seek regulatory approval on the modified manufacturing process in order to provide an extended shelf life product. Data continues to compare very positively with our earlier approved product, and we expect the extended shelf life product to meet the launch requirements of our commercial partners," said Chief Executive James Barder.
Futura said the new approved shelf life for the product will be decided by the regulator.
Futura shares were up 5.9% to 30.98 pence on Wednesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Futura Medical